Inhibikase Therapeutics (IKT)

IKT · NASDAQ
$1.48−0.07 (−4.52%)
At close on Nov 3
Loading prices…

Profile

Analysts

Earnings

Financials

Stability

Loading…

Dividends

Ownership

Peers